The Roslin Institute
Roslin Logo

Directors

The Interim Director and four deputy directors provide leadership at the Institute.

bruce whitelaw headshot

Interim Director

Professor Bruce Whitelaw is Interim Director and Professor of Animal Biotechnology.

Professor Whitelaw was Head of Division of Developmental Biology at the Institute for 12 years.

His world-renowned research group focuses on establishing robust methodologies for genome-editing livestock for biomedical and agricultural applications.

Profile page

 

Mark Stevens

Deputy Director (Research)

Professor Mark Stevens provides leadership with regard to the Institute’s research strategy and activities.

Professor Stevens is Personal Chair of Microbial Pathogenesis.

His research group focuses on animal and zoonotic diseases, as well as bacterial pathogenesis.

Profile page

 

Jayne Hope

Deputy Director (Culture and Equality)

Professor Jayne Hope provides leadership in promoting equality, diversity and inclusivity at the Institute.

Professor Hope is Personal Chair of Immunology.

Her research group focuses on innate immune responses to Mycobacteria and other bovine pathogens.

Profile page

 

Ross Houston

Deputy Director (Translation and Commercialisation)

Professor Ross Houston provides leadership regarding the Institute’s translation and commercialisation activities, and engagement with industry and international organisations.

Professor Houston is Personal Chair of Aquaculture Genetics. His research group focuses on understanding the genetic basis of disease resistance in aquaculture species, and developing methods of selective breeding for improved resistance.

Profile page

 

Paul Digard

Deputy Director (Emergence and Impact)

Professor Paul Digard assists the Director in identifying and evaluating emergent opportunities and provides leadership regarding the Institute's response to these.

Professor Digard is Chair of Virology and his research group focuses on replication and pathogenesis of influenza viruses. He co-ordinates the Institute’s Covid-19 research response.

Profile page